Pure Global

CEA ELISA(Pathozyme® CEA ELISA) - India CDSCO Medical Device Registration

CEA ELISA(Pathozyme® CEA ELISA) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2018/000005_a5d6e7f6c40d22d73cf6217461eeb3b6_6095bbc512e638dc575c4276a85bce11. This device is marketed under the brand name Pathozyme® Ovarian Cancer Antigen Ag 125 ELISA. The license holder is Omega DX (Asia) Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
CEA ELISA(Pathozyme® CEA ELISA)
UID: IMP/IVD/2018/000005_a5d6e7f6c40d22d73cf6217461eeb3b6_6095bbc512e638dc575c4276a85bce11

Brand Name

Pathozyme® Ovarian Cancer Antigen Ag 125 ELISA

Device Class

Class C

Approving Authority

CDSCO

Product Information

Pathozyme® CEA (Pathozyme® Ovarian Cancer Antigen Ag 125 ELISA) ELISA is an in-vitro diagnostic kit used for the quantitative determination of Carcinoembryonic Antigen (Pathozyme® Ovarian Cancer Antigen Ag 125 ELISA)in human serum

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing